Mohan Bala serves as Executive at Mersana Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mohan Bala has executed 6 insider transactions totaling $12.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 27, 2025 involved selling 77 shares valued at $762.
Mohan Bala currently holds 2,922 shares of Mersana Therapeutics, Inc. (MRSN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mohan Bala has been a net seller of MRSN stock. They have purchased $0 and sold $12.2K worth of shares.
Mohan Bala's most recent insider trade was on Oct 27, 2025, when they sold 77 shares at $9.90 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 16, 2024 | MRSN | $9.3K | Sale | 3,431 | $2.71 | Planned |
| Jan 13, 2024 | MRSN | $0 | Option Exercise | 8,750 | $N/A | Planned |
| Oct 26, 2023 | MRSN | $2.2K | Sale | 1,912 | $1.13 | Planned |
| Oct 25, 2023 | MRSN | $0 | Option Exercise | 6,250 | $N/A | Planned |